These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model. Pilat N; Farkas AM; Mahr B; Schwarz C; Unger L; Hock K; Oberhuber R; Aumayr K; Wrba F; Wekerle T J Heart Lung Transplant; 2014 Apr; 33(4):429-37. PubMed ID: 24468120 [TBL] [Abstract][Full Text] [Related]
6. Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism. Hock K; Mahr B; Schwarz C; Wekerle T Eur J Immunol; 2015 Sep; 45(9):2470-9. PubMed ID: 26200095 [TBL] [Abstract][Full Text] [Related]
7. Immune monitoring of transplant patients in transient mixed chimerism tolerance trials. Sykes M Hum Immunol; 2018 May; 79(5):334-342. PubMed ID: 29289741 [TBL] [Abstract][Full Text] [Related]
8. Facilitating cells as a venue to establish mixed chimerism and tolerance. Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294 [TBL] [Abstract][Full Text] [Related]
9. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts. Yu P; Xiong S; He Q; Chu Y; Lu C; Ramlogan CA; Steel JC Immunology; 2009 Aug; 127(4):500-11. PubMed ID: 19604303 [TBL] [Abstract][Full Text] [Related]
10. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527 [TBL] [Abstract][Full Text] [Related]
11. Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates. Chaudhry S; Kato Y; Weiner J; Alonso-Guallart P; Baker S; Woodland DC; Lefkowitch JH; Duran-Struuck R; Sondermeijer HP; Zitsman J; Sears ML; Wu A; Karolewski B; Houck PJ; Martinez M; Kato T; Sykes M; Griesemer AD Transplantation; 2020 Aug; 104(8):1580-1590. PubMed ID: 32732835 [TBL] [Abstract][Full Text] [Related]
12. Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance. Chen JC; Chang ML; Huang SF; Chang PY; Muench MO; Fu RH; Ou LS; Kuo ML Cell Transplant; 2008; 17(5):495-506. PubMed ID: 18714669 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
14. Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance. Im KI; Park MJ; Kim N; Lim JY; Park HS; Lee SH; Nam YS; Lee ES; Lee JH; Cho ML; Cho SG Stem Cells Dev; 2014 Oct; 23(19):2364-76. PubMed ID: 24804993 [TBL] [Abstract][Full Text] [Related]
15. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning. Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic and therapeutic role of regulatory T cells in tolerance through mixed chimerism. Pilat N; Wekerle T Curr Opin Organ Transplant; 2010 Dec; 15(6):725-30. PubMed ID: 20881493 [TBL] [Abstract][Full Text] [Related]
17. Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation. Kim N; Lee H; Shin J; Nam YS; Im KI; Lim JY; Lee ES; Kang YN; Park SH; Cho SG PLoS One; 2015; 10(5):e0126318. PubMed ID: 25961559 [TBL] [Abstract][Full Text] [Related]
18. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294 [TBL] [Abstract][Full Text] [Related]
19. Chimerism-based tolerance in organ transplantation: preclinical and clinical studies. Oura T; Cosimi AB; Kawai T Clin Exp Immunol; 2017 Aug; 189(2):190-196. PubMed ID: 28369830 [TBL] [Abstract][Full Text] [Related]
20. Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms. Mengrelis K; Muckenhuber M; Wekerle T Transplantation; 2023 Dec; 107(12):2473-2485. PubMed ID: 37046378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]